We would like to inform our patients that our practice is currently unable to prescribe weight loss reduction medications, including:
- Wegovy (semaglutide)
- Saxenda (liraglutide)
- Mounjaro (tirzepatide)
These medications are currently restricted to specialist weight management services (Tier 3 services) and are not available for routine prescribing in General Practice for weight loss purposes.
Who may qualify for specialist weight loss medication?
At present, NHS prescribing of these medications is strictly limited and is only considered in specific circumstances, such as:
- Patients with type 2 diabetes and a BMI of 35 or above (or BMI of 30 or above in certain ethnic groups or with other health risks).
- Patients must also be engaged in a specialist NHS Tier 3 weight management programme.
- Medication initiation and continuation are strictly managed by specialist services, not by General Practice.
Patients without diabetes are currently not eligible for NHS-funded medication for weight loss through General Practice.
How we can support you
- We can provide support and advice on healthy eating, physical activity, and weight management strategies.
- We can arrange referral to NHS weight management programmes or Tier 3 services where appropriate.
- For patients with type 2 diabetes and significant obesity, we may discuss referral pathways for specialist assessment.
We thank you for your understanding and remain committed to supporting you with safe, evidence-based approaches to weight management.
For more information, or to discuss referral options, please contact our healthcare team.